Literature DB >> 19888942

Subclinical atherosclerosis in patients with chronic psoriasis: a potential association.

S El-Mongy1, H Fathy, A Abdelaziz, E Omran, S George, N Neseem, N El-Nour.   

Abstract

BACKGROUND: The immunological abnormalities that lead to the development of psoriasis suggest that these patients may be at increased risk for other inflammatory state which may enhance atherosclerosis.
OBJECTIVE: To assess the presence of subclinical atherosclerosis in psoriatic patients who haven't associated traditional cardiovascular risk factors, and to correlate these findings with colour Doppler echocardiographic parameters.
METHODS: The study included 80 patients with chronic psoriasis together with 50 age and sex matched healthy volunteers served as control group. Patients who had classic cardiovascular risk factors or had cardiovascular or cerebrovascular events were excluded. Carotid artery intima-media thickness (IMT) and carotid plaques were measured in the carotid arteries by using high-resolution B-mode ultrasound. Also, echocardiographic study was performed using ultrasound imaging system in all cases and controls.
RESULTS: Patients with psoriasis had increased carotid artery IMT compared with controls (means 0.9 +/- 0.2 mm vs. 0.7 +/- 0.1 mm; P < 0.001). Carotid IMT positively correlated with patients age, duration of the disease and severity of psoriasis. There was no significant difference in echocardiographic parameters in psoriatic patients compared with controls, also no significant correlation between carotid IMT and echocardiographic parameters were observed in psoriatic patients.
CONCLUSION: The increased carotid artery IMT in patients with chronic psoriasis suggesting that chronic psoriasis is associated with subclinical atherosclerosis with increased risk of cardiovascular disease. So, dermatologists should advice their patients to avoid traditional cardiovascular risk factors and to routinely checkup to reduce cardiovascular morbidity and mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19888942     DOI: 10.1111/j.1468-3083.2009.03481.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  26 in total

1.  Psoriasis: it's more than just the skin.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2012-06-08       Impact factor: 5.922

2.  Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.

Authors:  Nehal N Mehta; YiDing Yu; Babak Saboury; Negar Foroughi; Parasuram Krishnamoorthy; Anna Raper; Amanda Baer; Jules Antigua; Abby S Van Voorhees; Drew A Torigian; Abass Alavi; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2011-05-16

3.  Carotid intima-media thickness and serum leptin in psoriasis.

Authors:  B Enany; A K El Zohiery; R Elhilaly; T Badr
Journal:  Herz       Date:  2011-12-01       Impact factor: 1.443

4.  Psoriasis and cardiovascular risk: strength in numbers.

Authors:  Joel M Gelfand; Rahat S Azfar; Nehal N Mehta
Journal:  J Invest Dermatol       Date:  2010-04       Impact factor: 8.551

5.  Psoriasis is an independent predictor of increased risk of allergic reaction during percutaneous coronary interventions. Big data analysis from the Polish National PCI Registry (ORPKI).

Authors:  Zbigniew Siudak; Kalina Wysocka-Dubielecka; Krzysztof Malinowski; Artur Dziewierz; Tomasz Tokarek; Krzysztof Plens; Dariusz Dudek
Journal:  Cardiol J       Date:  2018-08-29       Impact factor: 2.737

6.  Evaluation of subclinical atherosclerosis in Egyptian psoriatic patients.

Authors:  Raghda Ghonimy Elsheikh; Tarek El-Sayed Amin; Amal Ahmad El-Ashmawy; Samah Ibrahim Abd El-Fttah Abdalla
Journal:  J Saudi Heart Assoc       Date:  2013-12-18

7.  Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis.

Authors:  Rahat S Azfar; Nicole M Seminara; Daniel B Shin; Andrea B Troxel; David J Margolis; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2012-09

8.  Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study.

Authors:  H Maradit-Kremers; M Icen; F C Ernste; R A Dierkhising; M T McEvoy
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-03       Impact factor: 6.166

9.  Metabolic syndrome in patients with psoriatic disease.

Authors:  Joel M Gelfand; Howa Yeung
Journal:  J Rheumatol Suppl       Date:  2012-07

10.  Endothelial function is impaired in the cutaneous microcirculation of adults with psoriasis through reductions in nitric oxide-dependent vasodilation.

Authors:  Billie K Alba; Jody L Greaney; Sara B Ferguson; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-20       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.